IgG Proteases

About Evozyne

Evozyne is a private, pre-clinical stage biotech leveraging a closed-loop AI and high-throughput experimentation platform to engineer novel therapeutic proteins from scratch. The company focuses on high-unmet-need immune-mediated diseases, with an initial pipeline including IgG proteases, next-generation cytokines, and respiratory disease candidates. Founded by Paragon Biosciences and led by a team with deep biopharma and AI expertise, Evozyne aims to establish AI-designed proteins as a foundational therapeutic modality.

Therapeutic Areas